63 Results for "

anti-estrogenic

" in MedChemExpress (MCE) Product Catalog:
Products (63)

63 Results for "anti-estrogenic" in MCE Product Catalog:

5
5 Cited Publications
Cat. No.: HY-A0287
CAS No.: 911-45-5
Synonyms: Clomifene; (Z/E)-Enclomiphene; (Z/E)-Enclomifene
Target:  

Estrogen Receptor/ERR

Research Areas:  

Metabolic Disease Cancer

Clomiphene (Clomifene; (Z/E)-Enclomiphene; (Z/E)-Enclomifene) is an orally active ovulation-inducing agent. Clomiphene binds to hypothalamic estrogen receptors to elevate FSH levels, and exhibits antiestrogenic or estrogenic properties. Clomiphene can induce erturbations during meiotic maturation and cytogenetic abnormalities in mouse oocytes. Clomiphene ameliorates memory impairment in PCOS models. Clomiphene mobilizes cytosolic calcium and reduces viability in prostate cancer cells. Clomiphene can be used for the research of polycystic ovary syndrome (PCOS) and prostate cancer .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-16950A
CAS No.: 68392-35-8
Synonyms: Afimoxifene; 4-OHT
(E/Z)-4-Hydroxytamoxifen (Afimoxifene) is a racemic compound of (Z)-4-Hydroxytamoxifen and (E)-4-Hydroxytamoxifen isomers. (E/Z)-4-Hydroxytamoxifen is a selective estrogen receptor modulator with mixed estrogenic and antiestrogenic activity, which is also an active metabolite of Tamoxifen (HY-13757A). (E/Z)-4-Hydroxytamoxifen is an agonist of the G protein-coupled estrogen receptor (GPER) with relatively low affinity (100-1000 nM). (E/Z)-4-Hydroxytamoxifen is promising for research of cyclical mastalgia, such as breast pain, tenderness, and nodularity .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-119437
CAS No.: 1481401-71-1
Purity:  99.75%
Target:  

Estrogen Receptor/ERR

Research Areas:  

Cancer

FLTX1 is a fluorescent Tamoxifen derivative that can specifically label intracellular Tamoxifen-binding sites (estrogen receptors) under permeabilized and non-permeabilized conditions. FLTX1 exhibits the potent antiestrogenic properties of Tamoxifen in breast cancer cells. FLTX1 is devoid of the estrogenic agonistic effect on the uterus .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-16023
CAS No.: 252555-01-4
Synonyms: EM-652 hydrochloride; SCH 57068 hydrochloride
Target:  

Estrogen Receptor/ERR

Research Areas:  

Cancer

Acolbifene (EM-652) hydrochloride, an active metabolite of EM800, is an orally active, cancer-preventing selective estrogen receptor modulator (SERM). Acolbifene (EM-652) hydrochloride inhibits estradiol (E2)-induced transcriptional activity of ERα (IC50=2 nM) and ERβ (IC50=0.4 nM). Acolbifene (EM-652) hydrochloride exerts a potent and pure antiestrogenic action in the mammary gland and uterus. Anticarcinogenic properties .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-B0887
CAS No.: 52645-53-1
Synonyms: NRDC-143
Permethrin (NRDC-143) is an insecticide, acaricide and a high selectively inhibitor of the Mitochondrial complex I, found in sediment and water samples. Permethrin shows estrogenic in vivo and anti-estrogenic activity in vitro. Permethrin also acts as a neurotoxin affecting neuron membranes by prolonging Sodium channel activation. Permethrin decreases resistance to bacterial infections in medaka (Oryzias latipes) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-B0515
CAS No.: 138926-19-9
Synonyms: BM-210955; RPR-102289A
Target:  

Apoptosis

Research Areas:  

Metabolic Disease Cancer

Ibandronate Sodium Monohydrate (BM-210955; RPR-102289A) is an orally active, selective inhibitor of farnesyl pyrophosphate synthase (FPP synthase). Ibandronate Sodium Monohydrate can block the mevalonate pathway to inhibit the isoprenylation modification of small GTPases (such as RAS, RHO family proteins), induce tumor cell apoptosis and inhibit bone resorption. Ibandronate Sodium Monohydrate inhibits tumor cell proliferation (such as ER + breast cancer cells), promotes the expression of the pro-apoptotic gene FAS, and can produce synergistic anti-tumor effects with anti-estrogen compounds. Ibandronate Sodium Monohydrate is used in the study of osteoporosis and bone metastatic tumors (such as breast cancer bone metastasis) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-B1617A
CAS No.: 7619-53-6
Target:  

Estrogen Receptor/ERR

Research Areas:  

Metabolic Disease Endocrinology

Zuclomiphene citrate is a cis isomer of Clomiphene citrate (HY-B0463). Zuclomiphene citrate is orally active and has an antiestrogenic effect. Zuclomiphene can reduce cholesterol levels. Zuclomiphene citrate can be for the researches of endocrinology and metabolic disease .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-113251
CAS No.: 362-06-1
Synonyms: Catecholestrone
2-Hydroxyestrone (Catecholestrone) is a specific receptor-mediated antiestrogenic agent. 2-Hydroxyestrone is anticarcinogenic .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-121149
CAS No.: 82413-20-5
Purity:  99.89%
Synonyms: 3-Hydroxytamoxifen
Research Areas:  

Cancer

Droloxifene, a Tamoxifen derivative, is an orally active and selective estrogen receptor modulator. Droloxifene shows antiestrogenic and anti-implantation effects. Droloxifene induces p53 expression and apoptosis in MCF-7 cells. Droloxifene prevents bone loss in ovariectomized rats .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-B0515B
CAS No.: 138844-81-2
Target:  

Apoptosis

Research Areas:  

Metabolic Disease Cancer

Ibandronate Sodium is an orally active, selective inhibitor of farnesyl pyrophosphate synthase (FPP synthase). Ibandronate Sodium can block the mevalonate pathway to inhibit the isoprenylation modification of small GTPases (such as RAS, RHO family proteins), induce tumor cell apoptosis and inhibit bone resorption. Ibandronate Sodium inhibits tumor cell proliferation (such as ER+ breast cancer cells), promotes the expression of the pro-apoptotic gene FAS, and can produce synergistic anti-tumor effects with anti-estrogen compounds. Ibandronate Sodium is used in the study of osteoporosis and bone metastatic tumors (such as breast cancer bone metastasis) .
loading...
    loading...
Cat. No.: HY-B1234
CAS No.: 5466-77-3
Synonyms: Octyl methoxycinnamate
Octinoxate (Octyl methoxycinnamate) is a thyroid hormone receptor agonist, reducing the levels of triiodothyronine (T3) and thyroxine (T4) and transcription levels of genes related to type II deiodinase (deio2) in Japanese Medaka. Octinoxate is commonly used as a safe ultraviolet (UV) filter used in the aquatic environment. Octinoxate inhibits CYP1A1 and CYP1B1 to regulate hyaluronan (HA) (HY-B0633A) metabolism in a PI3K pathway-dependent manner in human keratinocytes. Octinoxate also exhibits an anti-estrogenic and anti-androgenic effect in vitro and in vivo .
loading...
    loading...
Cat. No.: HY-N1581
CAS No.: 76-78-8
Synonyms: Nigakilactone D
Quassin (Nigakilactone D) is a bioactive triterpenoid from stem bark extract of Quassia amara. Quassin inhibits P. falciparum with an IC50 of 0.15 μM. Quassin possesses reversible antifertility, anti-estrogenic and anti-plasmodial activity .
loading...
    loading...
Cat. No.: HY-B2158
CAS No.: 569-57-3
Chlorotrianisene is a long-acting non-steroidal estrogen and an orally active estrogen receptor modulator. Chlorotrianisene exhibits antiestrogenic activity. Chlorotrianisene potently inhibits the enzyme COX-1 and inhibits platelet aggregation in whole blood .
loading...
    loading...
Cat. No.: HY-148225
CAS No.: 261506-27-8
Purity:  94.79%
Target:  

Drug Metabolite

Research Areas:  

Cancer

Fulvestrant 3-β-D-Glucuronide, a metabolite, is glucuronide and sulfate conjugates of Fulvestrant (HY-13636), a pure anti-estrogenic steroid. Fulvestrant 3-β-D-Glucuronide can be used for the research of breast cancer .
loading...
    loading...
Cat. No.: HY-N1507
CAS No.: 33464-71-0
Tracheloside is an antiestrogenic lignin. Tracheloside promotes keratinocyte proliferation through ERK1/2 stimulation. Tracheloside is a good candidate to promote wound healing .
loading...
    loading...
Cat. No.: HY-16023B
CAS No.: 151533-34-5
Synonyms: EM-343; (Rac)-EM-652
Target:  

Estrogen Receptor/ERR

Research Areas:  

Cancer

(Rac)-Acolbifene (EM-343; (Rac)-EM-652) is the racemic form of EM652 (estrogen receptor?antagonist), has anti-estrogenic and estrogenic activities. (Rac)-Acolbifene (EM-343; (Rac)-EM-652) contains a piperidine ring, shows good pharmacological profile,relative binding affinity (RBA)=380 .
loading...
    loading...
Cat. No.: HY-18719D
CAS No.: 114828-90-9
Synonyms: E-Endoxifen
Target:  

Estrogen Receptor/ERR

Research Areas:  

Cancer

Endoxifen E-isomer (E-Endoxifen), an E-isomer of Endoxifen, is an impurity in Endoxifen Z-isomer agent substance. Endoxifen E-isomer exhibits antiestrogenic effects .
loading...
    loading...
Cat. No.: HY-13556
CAS No.: 182133-25-1
Synonyms: LY353381; SERM III
Target:  

Estrogen Receptor/ERR

Research Areas:  

Metabolic Disease Cancer

Arzoxifene (LY353381) is an orally active selective estrogen receptor modulator with a fixed ring structure similar to raloxifene. Arzoxifene has minimal side effects with powerful antiestrogenic effects on breast cancer and endometrium, with equally strong favorable estrogenic effects on bone and lipid profile .
loading...
    loading...
Cat. No.: HY-10830A
CAS No.: 262425-59-2
Purity:  99.30%
Target:  

Estrogen Receptor/ERR

Research Areas:  

Cancer

PBPE hydrochloride is a derivative of tamoxifen (HY-13757A) and a selective ligand for the anti-estrogen binding site (AEBS), the binding affinities (Ki) of PBPE hydrochloride and MBPE to AEBS are 8.79 and 17.57 nM, respectively .
loading...
    loading...
Cat. No.: HY-A0287S
CAS No.: 1346606-66-3
Synonyms: Clomifene-d5 hydrochloride; (Z/E)-Enclomiphene-d5 hydrochloride; (Z/E)-Enclomifene-d5 hydrochloride
Clomifene (Clomifene; (Z/E)-Enclomiphene; (Z/E)-Enclomifene)-d5 hydrochloride is a deuterium labeled Clomifene hydrochloride (HY-A0287A). Clomiphene hydrochloride is an orally active ovulation-inducing agent. Clomiphene hydrochloride binds to hypothalamic estrogen receptors to elevate FSH levels, and exhibits antiestrogenic or estrogenic properties. Clomiphene hydrochloride can induce erturbations during meiotic maturation and cytogenetic abnormalities in mouse oocytes. Clomiphene hydrochloride ameliorates memory impairment in PCOS models. Clomiphene hydrochloride mobilizes cytosolic calcium and reduces viability in prostate cancer cells. Clomiphene hydrochloride can be used for the research of polycystic ovary syndrome (PCOS) and prostate cancer .
loading...
    loading...